IBM's Think 2025 event focused on its portfolio of AI solutions for large enterprises. Analyst James Schneider maintains a Buy rating and $270 price target.
While Q1 GDP showed a modest contraction, labor markets and underlying domestic demand remained resilient, giving the Fed cover to delay any immediate rate cuts.
Applovin Corp (NASDAQ:APP) shares are facing selling pressure again after short seller Muddy Waters Research released a bearish report on the company, which follows an initial short report from March.
Shares of semiconductor materials supplier Entegris (NASDAQ:ENTG) fell 8.6% in the afternoon session after the company reported weak first quarter 2025 results which lacked standout positives, with revenue falling short of estimates and next quarter's revenue guidance missing significantly. The real concern came from the company's second-quarter outlook, which called for up to a 5% revenue decline sequentially and EBITDA margin compression, weighed by tariffs and weak U.S. sales to China. Overall, this quarter could have been better.
Shares of healthcare services company Agilon Health (NYSE:AGL) fell 24.9% in the afternoon session after the company reported weak first quarter 2025 results as new customer additions fell short.
Shares of water handling and recycling company Aris Water (NYSE:ARIS) fell 15.7% in the afternoon session after the company reported mixed first quarter 2025 results: its EBITDA guidance for next quarter missed. While management kept its full-year EBITDA outlook unchanged, second-quarter guidance implied a sequential decline due to deferred maintenance and lower skim oil prices. On the other hand, ARIS significantly beat analysts' revenue, EPS, and EBITDA expectations. Still, we think this was a weaker print.
Shares of personal care company Edgewell Personal Care (NYSE:EPC)
fell 12.4% in the afternoon session after the company reported weak first quarter 2025 results which included a beat on EBITDA expectations, but organic revenue missed and full-year EBITDA guidance fell short of Wall Street estimates. North American sales dragged things down, especially in shaving, feminine care, and sun products. Sales were down just over 3%, and while gross margins improved a bit from cost cuts, that couldn't offset lower volumes. What's more, EPC lowered their full-year sales and EBITDA outlook. Overall, this was a softer quarter.
Shares of online advertising giant Alphabet (NASDAQ:GOOGL)
fell 8.2% in the afternoon session after Apple's top services chief, Eddy Cue, said the company was testing AI search tools like Perplexity for Safari, hinting at a big change in how people search for information on Apple devices. This could hit Google hard, given that "search" is its bread and butter, and it pays (reportedly) Apple $20 billion annually to remain the default search engine on its devices.
Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN)
fell 36% in the afternoon session after the company reported mixed first quarter 2025 results: it lowered its full-year revenue, EPS, and EBITDA guidance due to weaker trends in its pharmacogenomics and hereditary cancer testing (women's health) businesses. On the other hand, MYGN significantly beat analysts' EPS and EBITDA expectations. Overall, this was a softer quarter.
Shares of biotech company Sarepta Therapeutics (NASDAQ:SRPT)
fell 20.5% in the afternoon session after the company reported weak first quarter 2025 results which featured drastically lowered full-year 2025 product revenue guidance and a major increase in operating expenses.
Shares of natural food company Hain Celestial (NASDAQ:HAIN)
fell 49% in the afternoon session after the company reported underwhelming first quarter 2025 results as it missed across revenue, EPS, and EBITDA, and its full-year EBITDA guidance fell short of Wall Street's estimates. Revenue was down 11%, and margins slipped a bit too, hurt by heavier discounting and slower demand. Overall, this quarter could have been better.
Shares of cybersecurity company CrowdStrike (NASDAQ:CRWD)
fell 5.1% in the morning session after the company announced a 5% cut to its workforce as part of efforts to stay more efficient using AI, though it planned to continue filling strategic roles in the current year. As part of the plan, the company expects to incur restructuring expenses, which could negatively affect its earnings in the year, and it is not clear if it will immediately offset the costs using its new efficiency plans.
Eos shares are trading higher Wednesday after the company reported better-than-expected first-quarter financial results on Tuesday after the market closed.
